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1 8 A  SYNOPSES OF 
Loss of Heterozygosity a t  PTEN in Sporadic Colorectal Adenomas  
Xinapei Hao1,2,3, IM Frayling2, TC Willcocks3, IC Talbot1.2 
lAcademic Department of Pathology, 
St Mark's Hospital, Harrow, HA1 3UJ 
ICRF Colorectal Unit, 
School of Bioscienccs, University of Wcstminster. 
PTEN, a putative tumour suppressor gene, has  been mapped to  
10q23.3. Mutations or  allelic loss a t  PTEN have been reported in  
malignant turnours such as glioblastoma, melanoma, breast, 
prostate, a n d  colorectal carcinomas; germ-line PTEN mutat ions 
have also been reported in  some juvenile polyposis families. 
To  investigate PTEN in sporadic colorectal adenomas, we 
examined allele loss (LOH) a t  D10S201. D10S215, D10S541 in 
microdissected tissues f rom 74 adenomas.  
Fifty-seven cases were informative, with seven adenomas 
(12.3%) showing L O H  a t  one  or more  loci. The  frequencies of 
L O H  in adenomas with mild, moderate  a n d  severe dysplasia 
were 6.3% (1/16), 12.0% (3/25 ) a n d  18.8% (3/16), respectively, 
showing that loss of PTEN m a y  be involved in  a subset of 
adenomas.  
These figures are  lower than the frequency of 35% reported in  
sporadic colorectal carcinomas, a n d  generally lower than the 
accepted 20% threshold for a significant frequency of LOH. Thus, 
loss of PTEN would appear to be associated with carcinoma 
rather than adenoma.  
This is consistent with observations in  other tumour types, 
where FTEN mutation appears  related to  generally more 
advanced malignancies. Further work is needed to define the 
possible =mutations in  these positive L O H  cases. 
BAG1 EXPRESSION IN NORMAL TISSUES, 
COLORECTAL ADENOMAS AND COLORECTAL 
CARCINOMAS 
M. Moorghen, A. Hague, G. Packham' and C. Paraskeva 
Department of Pathology and Microbiology, University of 
Bristol School of Medical Sciences, University Walk, Bristol 
BS8 1TD. 'Ludwig Institute for Cancer Research, Imperial 
College School of Medicine St Mary's London. 
Apoptosis is regulated by a large number of oncoproteins. Bcl-2 
protects against the development of apoptosis in a variety of 
normal and neoplastic tissues. The more recently described Bag- 
1 protein also suppresses apoptosis by a mechanism which is at 
least partly mediated via interaction with Bcl-2. In a previous 
study we demonstrated the differential expression of Bcl-2 in 
colonic crypt epithelium in a cytoplasmic distribution and the 
over-expression of Bcl-2 in colonic carcinomas and adenomas. 
In this study we studied a number of normal tissues and a series 
of colorectal adenomas and carcinomas for the expression of 
Bag-1 by immunohistochemistry using a polyclonal antibody. In 
normal skin immunoreactivity was present within most 
keratinocytes in a predominantly nuclear distribution with 
sparing of the granular layer. In the small intestine only 
occasional epithelial cells within the crypt were positive in a 
predominantly nuclear pattern. In the stomach positive staining 
was observed in a few mucus-secreting epithelial cells in the 
antrum again in a predominantly nuclear distribution but surface 
foveolar cells were negative. In the large intestine there was 
immunoreactivity of epithelial cells within the crypt and at the 
surface in both cytoplasmic and nuclear distributions. In most 
colonic adenomas and carcinomas there was strong nuclear 
staining; cytoplasmic immunoreactivity was also present in a 
stronger staining pattern than in adjacent non-neoplastic mucosa. 
These findings suggest a role for Bag-1 in colorectal neoplasia 
and are consistent with interaction with Bcl-2. 
PAPERS 
Infrequent expression of CD40 on colorectal cancer: association with 
advanced Dukes stage 
Christothea Constandinou', Joanne Flavell'. Derek Lowe', Kenneth Scott', 
Rajnee Tahim-, Jane Oates". John Cracker". Lawrence S Young *, Paul 
Murray". 
'School Of Health Sciences, University of Wolverhampton, Wolverhampton, 
WV1 IDJ, -Department of Histopathology, New Cross Hospital, 
Wolverhampton, WV10 OQP, "Department of Hislopathology, Birmingham 
Heartland's Hospital, Bordesley Green East, Birmingham, 89 5SS, and 'Institute 
for Cancer Studies, University of Birmingham, Edgbaston, Birmingham, 815 
2lT. 
We have used immunohistochernistly to investigate the expression of CD40 on 
a series of 160 cases of histologically confirmed cancers of the colon and 
rectum. CD40 was expressed by a minority of tumours (15/160), most of which 
showed a uniform Staining pattern throughout the tumour specimen. However, in 
some positive samples expression was either weak and/or localised to isolated 
regions within the tumour. CD40 expression was not seen in 23 turnours at 
Dukes A stage, but was expressed in 4/58 and 11/79 Dukes B and C turnours, 
respectively. This was also reflected in poorer survival for patients with CD40- 
expressing turnours, although this trend was not statistically significant. A 
proportion of these tumours were irnmunostained for HLA class I I  molecules. 
We found that expression of HLA Class II decreased, with more advanced 
Dukes stage (A; 12/17, 6; 22/44, C; 11/29). This data suggests that CD40 
expression in colorectal cancer may have a negative impact on tne outcome of 
patient survival and may implicate a role for CD40-mediated stimulated growth 
of these turnours. 
AVEKAGE VOLUME OF hIITOCHONUWION, NUCLEOLUS, 
HETER(K'HHOblATIN AND EUCHROMATIN IN IIEXAMETHY- 
LENE BISACETAMIDE (HMBA) ININJCEU HUMAN COLONIC 
CARClNOhlA CELL LINE (LOVO) 
T.Y.H. Lau, A.L.M. Cheung, G.L.Tipoe 
Deparhnent of Anatomy, The University of Hong Kong, Hong Kong. 
The present study aims to determine the effect of HMBA on the mitochondria1 
and nuclear components of LOVO (CCL-229) using electron microscopical 
and stereological techniques. 2mM and JmM of HMBA were included in the 
culture medium for a period of 7 days and then for a further 3 days HMBA- 
containing medium was omitted. Control flasks were never exposed to HMBA. 
The nuclear-cytoplasmic ratio, volume density of mitochondria ( V ~ C ) ,  
nucleolus (VVNCJ). heterochromatin (Vmi~)  and euchromatin (V,) were 
estimated using point counting. The nuclear volume (VN) was estimated from 
point-sampled intercepts. From these data cytoplasmic volume (VCYI), cell 
volume (V,,,,), average volume of mitochondrion per cell (VM,~) and average 
volume of nucleolus (VVN~J), hetsochromatin (VIiN) and euchromatin ( V ~ N )  
per nucleus were calculated. The general trend for the average volumes of the 
mitochonrion and nucleolus decreased and the heterochromatin increased in 
HMBA-treated groups when compared with the control. There was a denease 
in VW.C on day 3 to day 10 of the culture period with the control groups having 
the highest value when compared with the HMBA-treated ones. However, 
statistical significant differences were only detected on day 3 in the 4mM 
HMBA-treated group and on day 10 in both HMBA-treated groups. Similar 
reduction in the values of V ~ C  were observed except that the HMBA-treated 
groups had values higher than the control on day 10 but no significant 
difference was detected in all time points amongst the tested groups. Significant 
decrease in VVNC,N was observed on day I to day 5 in HMBA-treated groups. 
Similar trend was observed in VN~,N and significant difference was only 
observed on day I between HMBA-treated and control groups. No statistical 
significant difference was detected in VNC.N, V ~ K N .  VKN. VW.N and VBN 
between HMBA-treated and control groups from day 1 to day 10. We concldde 
that HMBA has no significant effect on the nuclear and cellular metabolic 
activity in the human colonic carcinoma cell line (LOVO). 
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